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The peptide C5a which 1s generated during the complement cascade 1s an important chemotactlc factor involved m the inflammatory response. 
The CSa receptor (CSaR) primary sequence suggests that It has a serpentine structure of seven transmembrane domains which IS typical of classical 
G-protein-coupled receptors. To investigate the slgnal transduction mechamsm of C5a we transiently expressed the CSaR in combmation with 
different G-protein a subunits m human kidney 293 cells and measured the PLC activity induced upon C5a stimulation. Cotransfection of C5aR 
and al6 stimulated PLC while cotransfectlon of C5aR with either a,, or IL,: did not. 
C5a receptor, Gal,,: Human kidney 293 cell 
1. INTRODUCTION 
The inflammatory response is amplified by specific 
chemotactic factors which direct the accumulation of 
necessary phagocytic cells. One of the chemotactic fac- 
tors involved is the 74 amino acid peptide C5a which is 
liberated by proteolytic cleavage from its precursor C.5 
during the complement cascade [I]. Chemotactic factors 
such as C5a, N-formylated peptides and leukotriene B4 
bind to cell surface receptors and initiate the chemotac- 
tic response [2]. C5a interacts with its receptor (CSaR) 
which is expressed in hematopoietic cells such as neutro- 
phils and eosinophils. Cloning of the CSaR revealed a 
‘serpentine’ structure of seven transmembrane domains 
typical of classical G-protein-coupled receptors [3]. The 
functional CSaR was purified from neutrophils as a 
receptor-G, complex [4] suggesting that at least part of 
the CSaR signal is transmitted by G,. Previous reports 
showed that transient expression of CSaR in human 
kidney 293 cells allowed a prominent increase in intra- 
cellular Ca’+ induced by stimulation with C5a. Pertussis 
toxin (PTX) catalyzes the ADP-ribosylation of a-sub- 
units of the G,-class and blocks the activation of the 
a-subunit by inhibiting subunit dissociation. Only 70% 
of the C5a induced rise in intracellular Ca’+ could be 
blocked by PTX-treatment of the cells prior to stimula- 
tion indicating that other G-proteins outside the G,- 
family must be involved in transmitting the C5aR signal 
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[5]. The rise in intracellular Ca’+ might be promoted by 
Pdt-Ins PLC-p hydrolysis of phosphatidylinositol 4,5- 
biphosphate (PIP,) generating DAG and inositol tris- 
phosphate (IP,), suggesting a possible involvement of 
G-proteins from the G,-family. In order to investigate 
the signaling of the CSaR we transiently transfected the 
CSaR alone and in combination with different G pro- 
tein a-subunits in human kidney 293 cells. Activation of 
Pdt-Ins PLC-p was obtained by treatment with C5a 
only by cotransfecting the CSaR with a,,. No stimula- 
tion of PLC-,8 was seen with cotransfections of CSaR 
and either cr, or q2. 
2. MATERIALS AND METHODS 
C5aR cDNA was originally from N. Gerard, Harvard Medical 
School. hGRPR cDNA was origmally from J. Battey, NIH. Recombi- 
nant C5a was purchased from Sigma and dissolved m PBS. 0.25% 
BSA. 
The M, muscarnnc receptor cDNA was Inserted mto the pCD 
expression vector. hGRPR cDNA, C5,aR cDNA as well as all a- 
subunit cDNAs were cloned into the expression plasmid pCMV5. The 
a,? cDNA was origmally provided by R. Reed [6]. The a, cDNA [7] 
was PCR cloned and sequenced as previously described [8]. A cDNA 
for the entlre translated sequence of z,, [9] was isolated using reverse 
transcrlptase and PCR of poly(A)’ RNA from HL-60 cells. The entire 
sequence wa5 verified by dideowy sequencing Human kidney 293 cells 
were split and seeded mto 60 mm dishes 24 h before transfectlon to 
obtam 3040% 293 cells at this density were trdnsfected with 1 5 yg 
of DNA / 60 mm dish by Ca” phosphate preclpltatlon method [IO]. 
After incubation with DNA for 6 h the cells were glycerol-shocked for 
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1 min and labeled with myo-[2-3H]inositol (1,Kilml, 23 Ci/mmol). 40 
h later the cells were starved in serum-free Dulbecco’s modified Eagle’s 
medium containing 0.1% BSA and tnyo-[2-3H]inositol (1 ,Ki/ml, 23 
Ci/mmol) for 12-18 h. 
2.3. Measurement of Pdt-Ins PLC actwit} 
Transfected cells labeled with myo-[2-3H]inosrtol were washed three 
times in serum-free medium and then incubated for 5 min in serum- 
free medium containing 20 mM LrCl. The cells were stimulated with 
agonist for 30 min, fixed in ice-cold methanol/HCl (lOO:l), scraped 
and placed into a tube containing chloroform (2 ml) and methanol/ 
HCl (final 2 ml). After thorough mixing and centrrfugation the aque- 
ous phase was passed over an AGI-X8 (200400 mesh) formate anion- 
exchange column to isolate inosttol phosphates [ll]. Total [‘Hlinosrtol 
incorporation was determined by measuring the radtoactivity of the 
organic phase. 
2.4. Expression anulysis of a &aim 
For rmmunoblots 25Opg of membrane protein from transfected 293 
cells was resolved on a sodium dodecyl sulphate-polyacrylamtde gel 
(10% acrylamide). transferred to nitrocellulose and probed wtth either 
~1,~ as or cc, specific antibodies. Each of the a subunit antibodies are 
polyclonal rabbit antibodies. Peptides were synthestzed corresponding 
to the carboxyl-terminal 12 amino acids for each a subunit, conjugated 
to keyhole limpet hemacyanin protein and used to immunize rabbits. 
The blots were probed with [“51]protein A and autoradtographed as 
previously described [ 12,131. 
3. RESULTS AND DISCUSSION 
Several lines of evidence suggest that multiple G pro- 
teins are involved in CSaR signaling. Functional C5aR 
was extracted from neutrophils as a CSaR-G, complex 
indicating that G, is involved in CSaR signaling [4]. 
However when CSaR was expressed in 293 cells only a 
portion of the CSa-induced rise in intracellular Ca’+ was 
blocked by pertussis toxin suggesting a possible role for 
additional G proteins outside the G, family [5]. Addi- 
tionally when C5a receptor cRNA was microinjected 
into Xenopus oocytes, functional signaling as measured 
by Ca’+ transients was not seen unless additional 
poly(A)’ RNA from undifferentiated HL-60 cells was 
introduced suggesting that a second protein was needed 
for CSaR signaling [14] The G protein Gc~,~ is restricted 
in its expression to cells of hematopoietic lineage [9]. 
To investigate the functional coupling of different 
a-subunits expressed in hematopoietic cells to the CSaR 
regulated Pdt-Ins PLC activation, 293 cells were used 
for transient expression analysis. For all experiments 
either the M, muscarinic receptor, which is known to 
couple to G, and stimulate PLC [15] or the human 
gastrin releasing peptide receptor (hGRPR), which 
stimulates PLC through activation of a pertussis toxin 
insensitive G protein [16,17], were used as controls. As 
shown in Fig. 1 neither transient transfection of the 
CSaR nor any of the a-subunits alone could promote 
PIP, breakdown upon C5a stimulation. We also exam- 
ined combinations of CSaR and either cc,, cl,: or CX,, 
subunits by transient cotransfection, stimulation with 
C5a and assayed PLC activity. Only 01,~ in combination 
with CSaR stimulated PLC activity upon agonist stimu- 
q - Carbachol 
+ Carbacbol 
Ftg. 1. Inositol phosphate formatron was measured as described m 
section 2 for a 30 min incubation in the presence or absence of ImM 
carbachol for 293 cells transfected with the M, receptor or for a 30 min 
incubation in the presence or absence of 100 nM C5a for cells trans- 
fected with vector only, a subunits only or cotransfections of C5aR 
and a subumts. Data points represent the mean + S.D. of triplicate 
measurements m a single experiment and are representatrve of three 
or more independent experiments. 
lation. No activation of PLC was found when CSaR was 
cotransfected with either ~1, or c1,, (Fig. 1). To further 
confirm the requirement for coupling between CSaR 
and ~1,~ for activation of PLC activity the CSaR was 
coexpressed with ~o~,,~, an inactive mutant a,, which 
cannot transmit a signal from the CSaR. This mutation 
is analogous to the previously characterized inactive 




Fig. 2. Inositol phosphate formation was measured as described in 
section 2 for a 30 min mcubatton in the presence or absence of 50 nM 
bombesm for 293 cells transfected with hGRPR or for a 30 mm 
incubation in the presence or absence of 100 nM C5a for cells trans- 
fected with C5aR only, a subumts only or cotransfections of C5aR 
and a subunits. Data points represent the mean + S.D. of trrplicate 
measurements in a single experiment and are representative of three 
or more independent experiments. 
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Fig. 3. lmmunoblots showing overexpression of a subumts in tran- 
siently transfected 293 cell membranes were prepared as described m 
section 2. None represents 293 cells transfected with only vector DNA 
and no receptor or a subunit DNA. 
G abG116A which cannot signal because it is unable to 
dissociate from j?y [18]. In contrast to the stimulation 
seen with C5aR and a,, the combination of C5aR and 
cq6G3,,A did not promote IP, breakdown (Fig. 2). The 
results seen in Figs. 1 and 2 clearly demonstrate that al6 
selectively interacts with the C5aR and is able to acti- 
vate Pdt-Ins PLC-/3 activity in 293 cells. Ga,? or CL, over- 
expression was unable to confer C5aR regulation of 
Pdt-Ins PLC activation. 
Immunoblotting with specific CY subunit antibodies 
revealed that 293 cells have or,, and a, but no alh present 
endogenously. Immunoblotting also showed that each 
of the a-subunits was overexpressed in transiently trans- 
fected 293 cells (Fig. 3). a,6G2,,A was also overexpressed 
to similar levels as CI,, in transiently transfected 293 cells 
(not shown). No change in endogenous j?y subunits is 
observed during the transient expression assay (not 
shown). A fraction of the cDNA expressed is able to 
associate with endogenous Py subunits allowing cou- 
pling to the C5aR [8,12,18]. 
Our results indicate that the C5aR can couple to more 
than one G protein. In mature neutrophils the C5aR 
appears to predominantly couple to G, [5]. However. it 
is clear that the C5aR can also efficiently couple to G,,. 
Thus, the signaling pathway utilized by the C5aR can 
vary depending on the relative expression of G,, and G, 
proteins. During HL-60 differentiation evidence sug- 
gests that CSaR’s are induced while expression of a,, is 
suppressed [9,19]. The expression of OL,? is not signifi- 
cantly altered during HL-60 differentiation [9]. This 
suggests that in mature differentiated cells CSaR regu- 
lates PLC-p, activity predominantly by By subunit com- 
plexes [20,21]. The role of a,, in CSaR signaling is un- 
clear, but might for example regulate the MAP kinase 
pathway [22]. During early phases of differentiation 
C5aR signaling is predicted to also involve G,, regula- 
tion of Pdt-Ins PLC activity. Thus. signal pathways 
regulated by serpentine receptors can couple to different 
G proteins. The ability of the C5aR to couple to two G 
proteins could confer significantly different second mes- 
senger responses during differentiation of cell types 
such as the neutrophil. The differential regulation of G 
protein CI, p and y subunit expression may be a signifi- 
cant regulatory mechanism during the differentiation of 
specific cell types. 
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